XML 73 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Jun. 28, 2014
Jun. 29, 2013
Jun. 30, 2012
Cash flows from operating activities:      
Net income $ 354,810 $ 454,912 $ 386,727
Adjustments to reconcile net income to net cash provided by operating activities:      
Stock-based compensation 85,452 83,808 89,867
Depreciation and amortization 244,593 207,136 211,096
Deferred taxes (32,159) 25,372 30,759
Research and Development in Process 2,580 2,800 1,600
Loss (gain) from sale of property, plant and equipment 2,187 (1,156) (7,648)
Loss (gain) from sale of equity investments 0 0 (1,811)
Tax benefit (shortfall) related to stock-based compensation (68) 8,197 3,112
Excess tax benefit related to stock-based compensation (14,192) (18,923) (17,482)
Net of Asset Impairment Charges 11,644 24,929 30,645
Gain (Loss) on Investments, Excluding Other than Temporary Impairments 10,260 700 0
Cash Provided by (Used in) Operating Activities, Discontinued Operations 0 (3,285) (45,372)
Changes in assets and liabilities:      
Accounts receivable 13,340 32,023 (19,262)
Inventories 20,672 (35,245) (432)
Other current assets 45,557 (21,233) (16,757)
Accounts payable (11,255) (32,510) 25,515
Income taxes payable 54,492 70,156 134,967
Deferred income on shipments to distributors (823) 277 (10,601)
All other accrued liabilities (10,983) 19,977 (38,201)
Net cash provided by operating activities 776,107 817,935 756,722
Cash flows from investing activities:      
Purchases of property, plant and equipment (132,523) (216,672) (264,348)
Proceeds from sale of property, plant, and equipment 5,293 19,196 16,883
Proceeds from Collection of Notes Receivable 0 10,786 0
Acquisitions (459,256) (2,767) (168,544)
Cash Provided by (Used in) Investing Activities, Discontinued Operations 0 0 56,607
Purchases of available-for-sale securities (49,953) 0 (25,108)
Payments to Acquire Investments 0 (500) (3,480)
Proceeds from Divestiture of Businesses 0 585 3,225
Proceeds from sales/maturities of available-for-sale securities 27,000 50,000 0
Net cash used in investing activities (609,439) (139,372) (384,765)
Cash flows from financing activities      
Excess tax benefit from stock-based compensation plans 14,192 18,923 17,482
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability (4,705) (13,781) 0
Repayment of notes payable (4,708) (303,500) (20,806)
Long-term debt, net of issuance costs 497,895 494,395 0
Payments of Debt Issuance Costs (3,431) (3,921) 0
Proceeds from Issuance of Common Stock (31,384) (29,042) (29,649)
Proceeds from Stock Options Exercised 69,639 71,342 49,906
Proceeds from Issuance of Shares under Incentive and Share-based Compensation Plans, Including Stock Options 42,809 36,297 33,772
Repurchase of common stock (305,314) (375,135) (246,412)
Dividends paid (294,175) (280,215) (257,731)
Net cash used in financing activities (19,182) (384,637) (453,438)
Net increase (decrease) in cash and cash equivalents 147,486 293,926 (81,481)
Cash and cash equivalents:      
Beginning of year 1,174,986 881,060 962,541
End of year 1,322,472 1,174,986 881,060
Supplemental disclosures of cash flow information:      
Cash (refunded) paid, net during the year for income taxes (6,455) 19,080 39,827
Cash paid for interest 22,861 10,624 10,890
Noncash financing and investing activities:      
Accounts payable related to property, plant and equipment purchases $ 14,474 $ 16,825 $ 26,079